Protect your family's future health by storing your newborn baby's cord blood and cord tissue stem cells

References

1. Delaney C et al. Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications. BR J Haematol. 2009 Oct; 147(2): 207-16. 

2. Broxmeyer HE. Cord blood hematopoietic stem cell transplantation. In: StemBook (Internet). Cambridge (MA): Harvard Stem Cell Institute; 2008-2010 May 26. 

3. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009 Oct; 147(2): 177-84. 

4. Nietfeld JJ, Pasquini MC, Logan Br, Verter F, Horowitz MM. Lifetime Probabilities of Hematopoietic Stem Cell Transplantation in the U.S. Biology of Blood and Marrow Transplantation March 2008; 14:316-322

5. Charron D. Autologous white blood cell transfusion: toward a younger immunity. Hum Immunol. 2007 Oct; 68(10): 805-12. Epub 2007 Aug 16 

6. Jozwiak S et al. Intracerebroventricular transplantation of cord blood-derived neural progenitors in a child with severe global brain ischemic injury. Cell Medicine, Part B of Cell Transplantation, Vol. 1, pp. 71-82, 2010. 

7. Gluckman E. Ten years of cord blood transplantation: from bench to bedside. Br J Haematol. 2009 Oct; 147(2): 192-9. 

8. Schlechta B et al. Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration. Circ J. 2010 Jan; 74(1): 188-94. Epub 2009 Nov 19.

9. Riegelsberger UM et al. Intravenous human umbilical cord blood transplantation for stroke: impact on infarct volume and caspase-3-dependent cell death in spontaneously hypertensive rats. Exp Neurol. 2011 Jan; 227(1): 218-23. Epub 2010 Nov 16. 

10. Farge D et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica. 2010 Feb; 95(2): 284-92. Epub 2009 Sept 22. 

11. Lee JH et al. Percutaneous transplantation of human umbilical cord blood-derived multipotent stem cells in a canine model of spinal cord injury. J Neurosurg Spine. 2009 Dec; 11(6): 749-57. 

12.Arufe M C et al. Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev. 2010 Dec 29. (Epub ahead of print).

13. Nishiyama N et al. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells. 2007 Aug; 25(8): 2017-24. Epub 2007 May 10. 

14. Greco N et al. Umbilical cord blood stem cells for myocardial repair and regeneration. Methods Mol Biol. 2010; 660: 29-52. 

15. Cao FJ et al. Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. Chin Med J (Engl). 2009 Jan 20; 122(2): 225-31. 

16. Malgieri A et al. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010 Sep 7; 3(4): 248-69.

17. Wang L et al. Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen Med. 2011 Jan; 6(1): 95-109. 

18. Yoo BY et al. Application of mesenchymal stem cells derived from bone marrow and umbilical cord in human hair multiplication. J Dermatol Sci. 2010 Nov; 60(2): 74-83. Epub 2010 Sep 16. 

19. Luo G et al. Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood. Wound Repair Regen. 2010 Sep-Oct; 18(5): 506-13. doi: 10.1111/j. 1524-475X.2010.00616.x. 

20. Catón J et al. Future dentistry: cell therapy meets tooth and periodontal repair and regeneration. J Cell Mol Med. 2010 Dec 28 doi: 10.1111/j. 1582-4934.2010.01251.x. (Epub ahead of print).

21. Yamada Y et al. Promising cell-based therapy for bone regeneration using stem cells from deciduous teeth, dental pulp, and bone marrow. Cell Transplant. 2010 Nov 5. (Epub ahead of print). 

22. Gandia C et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells. 2008 Mar; 26(3): 638-45. Epub 2007 Dec 13. 

23. Kiraly M et al. Differentiation potential of stem cells from human dental origin – promise for tissue engineering. J Physiol Pharmacol. 2009 Dec; 60 Suppl 7: 167-75. 

24. Vaglini F et al. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. Brain Res. 2011 Jan 7: 1367: 94-102. Epub 2010 Sep 18.

25. Yang R et al. Clones of ectopic stem cells in the regeneration of muscle defects in vivo. PLoS One. 2010 Oct 20; 5(10): e13547. 

26. Kerkis I et al. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J Transl Med 2008 Jul 3; 6: 35. 

27. Aspinall R et al. Immunity in the elderly: the role of the thymus. J Comp Pathol. 2010 Jan; 142 Suppl 1: S111-5. Epub 2009 Dec 1. 

28. Lombardi V et al. Dendritic cell modulation as a new interventional approach for the treatment of asthma. Drug News Perspect. 2009 Oct; 22(8): 445-51.

29. Corthay A. How do regulatory T cells work? Scand J Immunol. 2009 Oct; 70(4): 326-36. 

30. Ongrádi J et al. Factors that may impact on immunosenescence: an appraisal. Immun Ageing. 2010 Jun 14; 7: 7. 

31. Charron D. Autologous white blood cell transfusion: toward a younger immunity. Hum Immunol. 2007 Oct; 68(10): 805-12. Epub 2007 Aug 16. 

32. Jeras M et al. Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specificCD8 cytotoxic T cell clones for adoptive immunotherapy. J Biomed Biotechnol. 2010; 2010: 705215. Epub 2010 Mar 10.

33. Holland AM et al. Rejuvenation of the aging T cell compartment. Curr Opin Immunol. 2009 Aug; 21(4): 454-9. Epub 2009 Jul 14. 

34. Gattinoni L et al. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol. 2006 May; 6(5): 383-93. Wang QJ et al. 

35. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK. Chin J Cancer 2010 Jul; 29(7): 641-8. 

36. Lin CS et al. Definingadipose tissue-derived stem cells in tissue and in culture. Histol Histopathol. 2010 Jun; 25(6): 807-15.

37. Sanz-Ruiz R et al. Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transplant. 2009; 18(3): 245-54. 

38. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch. 2009 Apr; 76(2): 56-66. 

39. Nakao N et al. Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells. Am J Pathol. 2010 Aug; 177(2): 547-54. Epub 2010 Jun 17. 

40. Riordan NH et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009 Apr 24; 7: 29.

41. García-Olmo D. et al. Adipose-derived stem cells in Crohn’s rectovaginal fistula. Case Report Med. 2010; 2010: 961758. Epub 2010 Mar 7. 

42. Crop MJ et al. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev. 2010 Dec; 19(12): 1843-53. Epub 2010 Sep 29. 

43. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood: Mustapha Zeddou1*, Alexandra Briquet*, Biserka Relic{, Claire Josse{, Michel G. Malaise{, Andre´ Gothot*,Chantal Lechanteur1 and Yves Beguin*,Cell Biology International CBI20090414GOS.3d 29/3/10 21:19:05 Volume 000 (000) N pages 000–000 N doi:10.1042/CBI20090414